Scientists have found a hormone peptide called YY that presents a promising drug target for malabsorption in babies.
List view / Grid view
Cincinnati Children's Hospital Medical Centre
9 May 2016 | By Victoria White, Digital Content Producer
In laboratory tests on human cells and mouse models, an experimental therapy was shown to stop treatment-resistant glioblastoma and high-grade gliomas...